KARYOPHARM THERAPEUTICS INC

Historical 13F Holders

Symbol
KPTI
CUSIP
48576U205
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 48576U205 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13G/A
9.9% 11/16/2026
Event 9/30/2026
Adage Capital Management, L.P. 13G/A
8.9% 11/12/2026
Event 9/30/2026
T. Rowe Price Investment Management, Inc. 13G/A 6.6% 6/5/2026
Event 5/31/2026
Affinity Asset Advisors, LLC 13G/A
6.5% 11/13/2026
Event 9/30/2026
BlackRock, Inc. 13G 5.6% 7/28/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (10)
J. Wood Capital Advisors LLC 13G/A
4.99% 11/3/2025
Event 10/14/2025
Highbridge Capital Management LLC 13G/A 4.9% 11/14/2025
Event 9/30/2025
JPMorgan Chase & Co 13G/A 4.9% 10/17/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 4.7% 10/30/2025
Event 9/30/2025
Acorn Bioventures, L.P. 13G/A
4.5% 10/8/2026
Event 10/2/2026
Opaleye Management Inc. 13G/A
2.7% 5/11/2026
Event 3/31/2026
Goldman Sachs Group Inc 13G/A
0.9% 11/9/2026
Event 9/30/2026
Integrated Core Strategies (US) LLC 13G/A
0.2% 10/28/2026
Event 9/30/2026
Commodore Capital LP 13G/A
0% 8/14/2026
Event 6/30/2026
Ikarian Capital, LLC 13G
0% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 92 17.3 M $21.1M
2026 Q2 99 21.1 M $206M
2026 Q1 83 18.0 M $102M
2025 Q4 70 10.1 M $73.9M
2025 Q3 54 2.95 M $19.3M
2025 Q2 52 4.38 M $18.9M
2025 Q1 49 3.32 M $12.4M